Background: An issue of central importance for most neurological disorders is that of case definition. In the field of neuroepidemiology, case definition informs the design, conduct, and interpretation of research studies that range from observational to interventional studies, from case-control to cohort studies, and from descriptive to analytical studies. For essential tremor (ET), one of the most common neurological disorders, the issue of case definition is particularly important. Though traditionally viewed as a monochromatic disorder, recent years have seen an expansion of the clinical phenotype. In a recently proposed consensus statement on tremor, a proposal was made to separate from ET a new tentatively and uncertainly-defined entity characterized by the presence of additional neurological signs other than action tremor. This entity would be termed “ET-plus”. The aims of this invited paper are to discuss the impact of the proposed nomenclature on studies of ET neuroepidemiology. Summary: The proposed term “ET-plus” is based solely on clinical features and even these are not clearly defined. It is not based on differences in underlying etiology (e.g., genes) or pathology. As such, it is not grounded in underlying biological differences. The use of the term would have numerous research implications. As detailed here, it would greatly complicate or make impossible studies of the descriptive epidemiology of ET, association studies, cohort studies, and clinical trials in ET. Key Messages: The proposed designation has the potential to be very problematic for studies of the epidemiology of tremor. This, along with this questionable validity of the proposed nomenclature, calls its use into serious question.

1.
Louis ED, Ottman R, Clark LN. Clinical classification of borderline cases in the family study of essential tremor: an analysis of phenotypic features.
Tremor Other Hyperkinet Mov (N Y)
. 2014 Feb;4:220.
2.
Louis ED. The evolving definition of essential tremor: What are we dealing with?
Parkinsonism Relat Disord
. 2018 Jan;46 Suppl 1:S87–91.
3.
Bain P, Brin M, Deuschl G, Elble R, Jankovic J, Findley L, et al. Criteria for the diagnosis of essential tremor.
Neurology
. 2000;54(11 Suppl 4):S7.
4.
Elble RJ. Diagnostic criteria for essential tremor and differential diagnosis.
Neurology
. 2000;54(11 Suppl 4):S2-6.
5.
Deuschl G, Bain P, Brin M; Ad Hoc Scientific Committee. Consensus statement of the Movement Disorder Society on Tremor.
Mov Disord
. 1998;13(S3 Suppl 3):2–23.
6.
Gövert F, Becktepe JS, Deuschl G. Current concepts of essential tremor.
Rev Neurol (Paris)
. 2016 Aug - Sep;172(8-9):416–22.
7.
Helmich RC, Toni I, Deuschl G, Bloem BR. The pathophysiology of essential tremor and Parkinson’s tremor.
Curr Neurol Neurosci Rep
. 2013 Sep;13(9):378.
8.
Muthuraman M, Raethjen J, Koirala N, Anwar AR, Mideksa KG, Elble R, et al. Cerebello-cortical network fingerprints differ between essential, Parkinson’s and mimicked tremors.
Brain
. 2018 Jun;141(6):1770–81.
9.
Lenka A, Bhalsing KS, Panda R, Jhunjhunwala K, Naduthota RM, Saini J, et al. Role of altered cerebello-thalamo-cortical network in the neurobiology of essential tremor.
Neuroradiology
. 2017 Feb;59(2):157–68.
10.
Buijink AW, van der Stouwe AM, Broersma M, Sharifi S, Groot PF, Speelman JD, et al. Motor network disruption in essential tremor: a functional and effective connectivity study.
Brain
. 2015 Oct;138(Pt 10):2934–47.
11.
Coenen VA, Allert N, Paus S, Kronenbürger M, Urbach H, Mädler B. Modulation of the cerebello-thalamo-cortical network in thalamic deep brain stimulation for tremor: a diffusion tensor imaging study.
Neurosurgery
. 2014 Dec;75(6):657–69.
12.
Hallett M. Tremor: pathophysiology.
Parkinsonism Relat Disord
. 2014 Jan;20 Suppl 1:S118–22.
13.
Bhalsing KS, Saini J, Pal PK. Understanding the pathophysiology of essential tremor through advanced neuroimaging: a review.
J Neurol Sci
. 2013 Dec;335(1-2):9–13.
14.
Tröster AI, Woods SP, Fields JA, Lyons KE, Pahwa R, Higginson CI, et al. Neuropsychological deficits in essential tremor: an expression of cerebello-thalamo-cortical pathophysiology?
Eur J Neurol
. 2002 Mar;9(2):143–51.
15.
Louis ED. Re-thinking the biology of essential tremor: from models to morphology.
Parkinsonism Relat Disord
. 2014 Jan;20 Suppl 1:S88–93.
16.
Louis ED. Linking Essential Tremor to the Cerebellum: neuropathological Evidence.
Cerebellum
. 2016 Jun;15(3):235–42.
17.
Louis ED, Lee M, Babij R, Ma K, Cortés E, Vonsattel JP, et al. Reduced Purkinje cell dendritic arborization and loss of dendritic spines in essential tremor.
Brain
. 2014 Dec;137(Pt 12):3142–8.
18.
Babij R, Lee M, Cortés E, Vonsattel JP, Faust PL, Louis ED. Purkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains.
Brain
. 2013 Oct;136(Pt 10):3051–61.
19.
Kuo SH, Tang G, Louis ED, Ma K, Babji R, Balatbat M, et al. Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau.
Acta Neuropathol
. 2013 Jun;125(6):879–89.
20.
Paris-Robidas S, Brochu E, Sintes M, Emond V, Bousquet M, Vandal M, et al. Defective dentate nucleus GABA receptors in essential tremor.
Brain
. 2012 Jan;135(Pt 1):105–16.
21.
Lin CY, Louis ED, Faust PL, Koeppen AH, Vonsattel JP, Kuo SH. Abnormal climbing fibre-Purkinje cell synaptic connections in the essential tremor cerebellum.
Brain
. 2014 Dec;137(Pt 12):3149–59.
22.
Choe M, Cortés E, Vonsattel JP, Kuo SH, Faust PL, Louis ED. Purkinje cell loss in essential tremor: random sampling quantification and nearest neighbor analysis.
Mov Disord
. 2016 Mar;31(3):393–401.
23.
Louis ED, Faust PL, Vonsattel JP, Honig LS, Rajput A, Robinson CA, et al. Neuropathological changes in essential tremor: 33 cases compared with 21 controls.
Brain
. 2007 Dec;130(Pt 12):3297–307.
24.
Yu M, Ma K, Faust PL, Honig LS, Cortés E, Vonsattel JP, et al. Increased number of Purkinje cell dendritic swellings in essential tremor.
Eur J Neurol
. 2012 Apr;19(4):625–30.
25.
Kuo SH, Erickson-Davis C, Gillman A, Faust PL, Vonsattel JP, Louis ED. Increased number of heterotopic Purkinje cells in essential tremor.
J Neurol Neurosurg Psychiatry
. 2011 Sep;82(9):1038–40.
26.
Louis ED, Kuo SH, Tate WJ, Kelly GC, Gutierrez J, Cortes EP, et al. Heterotopic Purkinje Cells: a Comparative Postmortem Study of Essential Tremor and Spinocerebellar Ataxias 1, 2, 3, and 6.
Cerebellum
. 2018 Apr;17(2):104–10.
27.
Delay C, Tremblay C, Brochu E, Paris-Robidas S, Emond V, Rajput AH, et al. Increased LINGO1 in the cerebellum of essential tremor patients.
Mov Disord
. 2014 Nov;29(13):1637–47.
28.
Shill HA, Adler CH, Sabbagh MN, Connor DJ, Caviness JN, Hentz JG, et al. Pathologic findings in prospectively ascertained essential tremor subjects.
Neurology
. 2008 Apr;70(16 Pt 2):1452–5.
29.
Louis ED, Rios E, Rao AK. Tandem gait performance in essential tremor: clinical correlates and association with midline tremors.
Mov Disord
. 2010 Aug;25(11):1633–8.
30.
Singer C, Sanchez-Ramos J, Weiner WJ. Gait abnormality in essential tremor.
Mov Disord
. 1994 Mar;9(2):193–6.
31.
Kronenbuerger M, Konczak J, Ziegler W, Buderath P, Frank B, Coenen VA, et al. Balance and motor speech impairment in essential tremor.
Cerebellum
. 2009 Sep;8(3):389–98.
32.
Parisi SL, Héroux ME, Culham EG, Norman KE. Functional mobility and postural control in essential tremor.
Arch Phys Med Rehabil
. 2006 Oct;87(10):1357–64.
33.
Filip P, Lungu OV, Bareš M. Dystonia and the cerebellum: a new field of interest in movement disorders?
Clin Neurophysiol
. 2013 Jul;124(7):1269–76.
34.
Kaji R, Bhatia K, Graybiel AM. Pathogenesis of dystonia: is it of cerebellar or basal ganglia origin?
J Neurol Neurosurg Psychiatry
. 2018 May;89(5):488–92.
35.
Putzke JD, Whaley NR, Baba Y, Wszolek ZK, Uitti RJ. Essential tremor: predictors of disease progression in a clinical cohort.
J Neurol Neurosurg Psychiatry
. 2006 Nov;77(11):1235–7.
36.
Louis ED, Agnew A, Gillman A, Gerbin M, Viner AS. Estimating annual rate of decline: prospective, longitudinal data on arm tremor severity in two groups of essential tremor cases.
J Neurol Neurosurg Psychiatry
. 2011 Jul;82(7):761–5.
37.
Louis ED, Frucht SJ, Rios E. Intention tremor in essential tremor: prevalence and association with disease duration.
Mov Disord
. 2009 Mar;24(4):626–7.
38.
Cohen O, Pullman S, Jurewicz E, Watner D, Louis ED. Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics.
Arch Neurol
. 2003 Mar;60(3):405–10.
39.
Louis ED, Hernandez N, Michalec M. Prevalence and correlates of rest tremor in essential tremor: cross-sectional survey of 831 patients across four distinct cohorts.
Eur J Neurol
. 2015 Jun;22(6):927–32.
40.
Louis ED, Rios E, Applegate LM, Hernandez NC, Andrews HF. Jaw tremor: prevalence and clinical correlates in three essential tremor case samples.
Mov Disord
. 2006 Nov;21(11):1872–8.
41.
Louis ED, Gerbin M, Galecki M. Essential tremor 10, 20, 30, 40: clinical snapshots of the disease by decade of duration.
Eur J Neurol
. 2013 Jun;20(6):949–54.
42.
Stolze H, Petersen G, Raethjen J, Wenzelburger R, Deuschl G. The gait disorder of advanced essential tremor.
Brain
. 2001 Nov;124(Pt 11):2278–86.
43.
Louis ED. Essential Tremor with Head Tremor: trait or State?
Can J Neurol Sci
. 2016 May;43(3):443–4.
44.
Thawani SP, Schupf N, Louis ED. Essential tremor is associated with dementia: prospective population-based study in New York.
Neurology
. 2009 Aug;73(8):621–5.
45.
Bermejo-Pareja F, Louis ED, Benito-León J; Neurological Disorders in Central Spain (NEDICES) Study Group. Risk of incident dementia in essential tremor: a population-based study.
Mov Disord
. 2007 Aug;22(11):1573–80.
46.
Benito-León J, Louis ED, Mitchell AJ, Bermejo-Pareja F. Elderly-onset essential tremor and mild cognitive impairment: a population-based study (NEDICES).
J Alzheimers Dis
. 2011;23(4):727–35.
47.
Shill HA, Hentz JG, Jacobson SA, Belden C, Sabbagh MN, Beach TG, et al. Essential Tremor in the Elderly and Risk for Dementia.
J Neurodegener Dis
. 2014;2014:328765.
48.
Louis ED, Joyce JL, Cosentino S. Mind the gaps: What we don't know about cognitive impairment in essential tremor.
Parkinsonism Relat Disord
. 2019 Jun;63:10–19.
49.
Louis ED. Non-motor symptoms in essential tremor: A review of the current data and state of the field.
Parkinsonism Relat Disord
. 2016 Jan;22 Suppl 1:S115–8.
50.
Ondo WG, Sutton L, Dat Vuong K, Lai D, Jankovic J. Hearing impairment in essential tremor.
Neurology
. 2003 Oct;61(8):1093–7.
51.
Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society.
Mov Disord
. 2018 Jan;33(1):75–87.
52.
Louis ED. Essential tremor: “Plus” or “Minus”. Perhaps now is the time to adopt the term “the essential tremors”.
Parkinsonism Relat Disord
. 2018 Nov;56:111–2.
53.
Prasad S, Pal PK. Reclassifying essential tremor: implications for the future of past research.
Mov Disord
. 2019 Mar;34(3):437.
54.
Rajalingam R, Breen DP, Lang AE, Fasano A. Essential tremor plus is more common than essential tremor: insights from the reclassification of a cohort of patients with lower limb tremor.
Parkinsonism Relat Disord
. 2018 Nov;56:109–10.
55.
Rajalingam R, Breen DP, Chen R, Fox S, Kalia LV, Munhoz RP, et al. The clinical significance of lower limb tremors.
Parkinsonism Relat Disord
. 2019 Aug;65:165–171.
56.
Hopfner F, Deuschl G. Is essential tremor a single entity?
Eur J Neurol
. 2018 Jan;25(1):71–82.
57.
Louis ED, Wendt KJ, Ford B. Senile tremor. What is the prevalence and severity of tremor in older adults?
Gerontology
. 2000 Jan-Feb;46(1):12–6.
58.
Louis ED. Twelve clinical pearls to help distinguish essential tremor from other tremors.
Expert Rev Neurother
. 2014 Sep;14(9):1057–65.
59.
Zubair A, Cersonsky TEK, Kellner S, Huey ED, Cosentino S, Louis ED. What Predicts Mortality in Essential Tremor? A Prospective, Longitudinal Study of Elders.
Front Neurol
. 2018 Dec;9:1077.
60.
van Egmond ME, Contarino MF, Lugtenberg CH, Peall KJ, Brouwer OF, Fung VS, et al. Variable Interpretation of the Dystonia Consensus Classification Items Compromises Its Solidity.
Mov Disord
. 2019 Mar;34(3):317–20.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.